2026 жылында Италияда глиобластоманың емдеу бойынша ең жақсы бағалар мен клиникалар туралы біліңіз

Top hospitals in Italy for glioblastoma treatment include San Raffaele Hospital, Humanitas Research Hospital, and Agostino Gemelli University Policlinic. These centers offer advanced neuro-oncology, 3 Tesla MRI imaging, and specialized neurosurgery. Many institutions maintain JCI accreditation and IRCCS status for excellence in clinical research.

• Advanced radiosurgery: San Raffaele Hospital has performed over 10,000 Gamma Knife procedures.
• Specialized neurosurgery: Dr. Pietro Mortini at San Raffaele specializes in complex microsurgical brain therapies.
• High patient volume: San Donato Hospital treats approximately 300,000 patients annually across various departments.
• Integrated research: IRCCS-accredited centers combine patient assistance with active clinical and molecular research.

Bookimed Expert Insight: While many patients look for large cancer centers, the IRCCS accreditation is the most reliable quality signal in Italy. This government-granted status confirms a hospital integrates the latest research directly into clinical practice. San Donato Hospital holds this distinction, ensuring patients access diagnostic protocols that meet high national research standards.

Patient Consensus: Patients note that Milan-based centers offer the best trial access but suggest using private options to reduce wait times. Many emphasize the importance of identifying MGMT methylation status early for personalized chemotherapy planning.

Standard care in Italy follows the Stupp protocol, combining maximal surgical resection with direct adjuvant therapy. Specialists utilize advanced imaging like 5-ALA fluorescence to define tumor margins. This is followed by 6 weeks of radiation and temozolomide chemotherapy. Treatment usually begins within 2–4 weeks of diagnosis.

• Surgical resection: Surgeons aim for maximal tumor removal while preserving critical neurological functions.
• Stupp regimen: Protocol includes 60 Gy radiation with daily oral temozolomide chemotherapy.
• Maintenance phase: Patients undergo 6 to 12 cycles of chemotherapy after a 4-week recovery.
• Genetic profiling: MGMT promoter methylation testing is standard to predict chemotherapy response.
• Recurrence options: Treatment may include regorafenib, second-line surgery, or Tumor Treating Fields (TTFields).

Bookimed Expert Insight: Italian neuro-oncology emphasizes high-volume surgical expertise. Academic centers like San Raffaele in Milan manage complex cases with surgeons like Dr. Pietro Mortini who has 30+ years of experience. Research-focused IRCCS facilities integrate clinical trials and advanced diagnostics directly into the standard treatment pathway. This structure often allows for a faster transition from surgery to radiation compared to other European systems.

Patient Consensus: Patients note that major centers in Milan and Rome offer very fast access to surgery. They emphasize the importance of having a multidisciplinary tumor board review every imaging scan to track recovery progress.

Specialized glioblastoma care in Italy includes Gamma Knife radiosurgery and advanced resection techniques. Leading research institutions provide access to CAR NK cell therapy and oncothermia. Patients may also qualify for regional clinical trials exploring immunotherapy and localized chemotherapy delivery protocols.

• Surgical innovation: Neurosurgeons use Halcyon and microsurgical techniques for precise tumor resection.
• Radiosurgery access: Gamma Knife provides targeted radiation while sparing surrounding healthy brain tissue.
• Cellular immunotherapy: CAR NK cell therapy is available as a specialized treatment approach.
• Clinical research: IRCCS-accredited centers combine patient care with experimental ministry-approved research activity.

Bookimed Expert Insight: Italian neurosurgery stands out because top specialists often hold international academic roles. For example, Dr. Pietro Mortini at San Raffaele has patented biological tissue regeneration devices. Choosing a surgeon with 30+ years of experience who also leads research ensures access to the latest surgical patents and experimental tools before they go mainstream.

Patient Consensus: Patients note that finding clinical trials in Italy requires self-advocacy and checking global registries earlier than expected. They often recommend specifically asking about Optune therapy, as it is a standard non-experimental option that medical teams sometimes overlook.

Italian centers treating glioblastoma provide dedicated support for international patients through specialized infrastructure. Professional medical interpreters and multilingual staff facilitate English-speaking consultations. Hospitals in Milan and Bari often offer logistical help with medical records, travel visas, and lodging arrangements.

• Language support: Free interpretation is common in facilities receiving specific government funding.
• Coordination services: Dedicated representatives assist with appointment scheduling and travel logistics.
• Medical translation: Certified translators ensure technical terms in consent forms are clear.
• Cultural assistance: Staff are often trained to meet diverse religious and linguistic needs.

Bookimed Expert Insight: Patient volume impacts support quality in Italy. San Donato Hospital manages 300,000 patients annually with a staff of 350 doctors. This high traffic usually means they have established systems for international visitors. Choosing a specialist like Dr. Pietro Mortini at San Raffaele provides access to world-class neurosurgery and experienced multilingual coordination teams.

Patient Consensus: Patients note it is important to hire a certified medical translator for technical discussions. They also recommend targeting private hospital wings where English access is more consistent.